Stronger chemo may help avoid surgery in rectal cancer trial
Disease control
Not yet recruiting
This study tests if a stronger chemotherapy combination (FOLFOXIRI) before standard chemoradiation leads to better tumor disappearance and quality of life compared to a standard combination (CAPOX/FOLFOX) in people with high-risk locally advanced rectal cancer. About 394 particip…
Phase: PHASE3 • Sponsor: J. W. A. Burger • Aim: Disease control
Last updated May 26, 2026 12:03 UTC